Marie Overgaard

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi request reprint [Postoperative radiotherapy treatment of early breast cancer]
    Marie Overgaard
    Arhus Universitetshospital, Arhus Sygehus
    Ugeskr Laeger 169:2993-6. 2007
  2. ncbi request reprint Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials
    Marie Overgaard
    Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 82:247-53. 2007
  3. doi request reprint Shoulder disability and late symptoms following surgery for early breast cancer
    Mette Cathrine Lauridsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 47:569-75. 2008
  4. ncbi request reprint Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark
    J Clin Oncol 24:2268-75. 2006
  5. doi request reprint High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 90:74-9. 2009
  6. doi request reprint Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer
    Hanna R Mortensen
    Department of Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 52:1535-42. 2013
  7. doi request reprint Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 50:1006-14. 2011
  8. ncbi request reprint Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation
    Jørgen Johansen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Acta Oncol 46:525-33. 2007
  9. doi request reprint Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
    Hanna R Mortensen
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
    Radiother Oncol 103:69-75. 2012
  10. ncbi request reprint Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 79:147-55. 2006

Collaborators

Detail Information

Publications34

  1. ncbi request reprint [Postoperative radiotherapy treatment of early breast cancer]
    Marie Overgaard
    Arhus Universitetshospital, Arhus Sygehus
    Ugeskr Laeger 169:2993-6. 2007
    ..However, there is a continuous need to find the overall balance between the risk and benefit of RT based on individual prognostic parameters and technical possibilities...
  2. ncbi request reprint Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials
    Marie Overgaard
    Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 82:247-53. 2007
    ..A subgroup analysis of the DBCG 82 b&c trials was performed to evaluate the loco-regional recurrence rate and survival in relation to number of positive nodes...
  3. doi request reprint Shoulder disability and late symptoms following surgery for early breast cancer
    Mette Cathrine Lauridsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 47:569-75. 2008
    ....
  4. ncbi request reprint Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark
    J Clin Oncol 24:2268-75. 2006
    ..The aim of this analysis was to examine the overall disease recurrence pattern among patients randomly assigned to receive treatment with or without RT...
  5. doi request reprint High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 90:74-9. 2009
    ..International consensus reports recommend postmastectomy radiotherapy only to patients at high risk of a local recurrence (LR)...
  6. doi request reprint Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer
    Hanna R Mortensen
    Department of Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 52:1535-42. 2013
    ..Prognostic factors are numerous and their interrelationship not well understood. The aim of this study was to establish a multivariate prognostic model for acute and late dysphagia after RT, based on information from a prospective trial...
  7. doi request reprint Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 50:1006-14. 2011
    ..Aim of the current analysis was to gain additional power by adding patients from the continued subrandomization in the DAHANCA 7 trial, now including a total of almost 1200 patients...
  8. ncbi request reprint Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation
    Jørgen Johansen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Acta Oncol 46:525-33. 2007
    ..Axillary irradiation increased the incidence of moderate to severe breast fibrosis in both premenopausal and postmenopausal patients...
  9. doi request reprint Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
    Hanna R Mortensen
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
    Radiother Oncol 103:69-75. 2012
    ..The aim of this report was to describe the incidence and prevalence of acute and late morbidity in the DAHANCA 6&7 multicentre randomised trial with accelerated radiotherapy for squamous cell carcinoma of the head and neck...
  10. ncbi request reprint Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 79:147-55. 2006
    ..The aim of the present study was to identify risk factors for loco-regional recurrence (LRR), to evaluate the treatment of LRR and to examine the prognosis after LRR...
  11. doi request reprint Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arhus Sygehus, Noerrebrogade 44, Building 5, 2, DK 8000 Aarhus C, Denmark
    J Clin Oncol 26:1419-26. 2008
    ....
  12. doi request reprint The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 100:49-55. 2011
    ..We aimed to assess the influence of tumour HPV-status, expressed by p16, on the response to accelerated fractionated radiotherapy in HNSCC through evaluation of the DAHANCA 6&7 trial...
  13. doi request reprint Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group
    Mette S Thomsen
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
    Acta Oncol 47:654-61. 2008
    ..The work was initiated in 2003 and the guidelines were approved by the DBCG Radiotherapy Committee in 2006. The first of January 2007 the 3D guidelines had been fully implemented in five of the seven radiotherapy centres...
  14. doi request reprint Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group
    Marianne Ewertz
    Department of Oncology, Odense University Hospital, University of Southern Denmark, Denmark
    Acta Oncol 47:682-90. 2008
    ..This formed the basis for recommending breast conserving surgery combined with radiotherapy as a standard treatment for suited breast cancer patients in Denmark...
  15. ncbi request reprint Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study
    Jørgen Johansen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Head Neck 30:471-8. 2008
    ..The benefit of a complementary fluorodeoxyglucose-positron emission tomography (FDG-PET) scan to standard workup for carcinoma of unknown primary (CUP) and metastatic neck lesions was prospectively studied...
  16. ncbi request reprint Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy
    Hanne Melgaard Nielsen
    Department of Experimental Clinical Oncology, Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 76:285-92. 2005
    ..The aim of the present study was to describe the delivered RT for the 1538 patients who were randomised to RT, and to evaluate the compliance with the RT guidelines...
  17. doi request reprint Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review
    Birgitte V Offersen
    Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    Radiother Oncol 90:1-13. 2009
    ..Patient selection for this therapy is pivotal and based on evidence from previous studies on patient/tumour characteristics and pattern of local recurrences we propose inclusion criteria for patients in APBI protocols...
  18. doi request reprint Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer
    Bent Ejlertsen
    Department of Oncology, Bldg 4262 Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Natl Cancer Inst 101:729-35. 2009
    ....
  19. doi request reprint The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 98:28-33. 2011
    ..The aim of the study was to evaluate the prognostic significance of low Hb level and its modification by transfusion in HNSCC patients treated with radiotherapy. The study was performed as a subrandomization in the DAHANCA 5 trial...
  20. doi request reprint Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: the DBCG-IMN study
    Lise B J Thorsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    Acta Oncol 52:1526-34. 2013
    ..In the study, standard DBCG IMN-RT was provided only to patients with right-sided BC. We provide estimates of doses to IMNs and organs at risk (OARs) in patients treated with the non-CT-based RT techniques used during the DBCG-IMN study...
  21. ncbi request reprint ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy
    Christian N Andreassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    Int J Radiat Oncol Biol Phys 64:776-83. 2006
    ....
  22. doi request reprint CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects
    Lise B J Thorsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 53:1027-34. 2014
    ..This study estimates IMN doses and doses to organs at risk (OAR) in patients from the DBCG-IMN. Numbers needed to harm (NNH) if patients with left-sided breast cancer had received IMN-RT are compared to the number needed to treat (NNT)...
  23. doi request reprint Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience
    Marie Overgaard
    Department of Oncology and Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark
    Acta Oncol 47:639-53. 2008
    ....
  24. ncbi request reprint [Survey of a Cochrane review concerning sequencing of adjuvant chemotherapy and postoperative radiotherapy in breast cancer]
    Hanne Melgaard Nielsen
    Arhus Universitetshospital, Arhus Sygehus, Onkologisk afdeling
    Ugeskr Laeger 169:3101-4. 2007
  25. ncbi request reprint Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA
    Hanne Primdahl
    Department of Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 45:156-61. 2006
    ..The prolongation was mainly related to shortage of radiotherapy capacity. The three weeks extra pretreatment delay could theoretically lead to a 10% lower tumor control probability in 2002 compared to 1992...
  26. pmc Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Arhus University Hospital, Nørrebrogade, 8000 Arhus C, Denmark
    Breast Cancer Res 10:R24. 2008
    ..The purpose of the present study was to examine the importance of CA IX to response to postmastectomy radiotherapy in the larger scaled DBCG82 b and c studies...
  27. ncbi request reprint Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes
    Christian Nicolaj Andreassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C DK 8000, Denmark
    Radiother Oncol 69:127-35. 2003
    ..This study investigates whether seven selected SNPs in five candidate genes influence risk of subcutaneous fibrosis and telangiectasia after radiotherapy...
  28. ncbi request reprint Morbidity after ipsilateral radiotherapy for oropharyngeal cancer
    Kenneth Jensen
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
    Radiother Oncol 85:90-7. 2007
    ..We wanted to study the consequences of volume sparring on all prospectively registered morbidity endpoints...
  29. ncbi request reprint Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial
    Jens Overgaard
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, Building 5, DK 8000 C, Aarhus, Denmark
    Lancet 362:933-40. 2003
    ..We aimed to find out whether shortening of treatment time by use of six instead of five radiotherapy fractions per week improves the tumour response in squamous-cell carcinoma...
  30. ncbi request reprint Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA
    Cai Grau
    Department of Oncology, Aarhus University Hospital, 8000 Aarhus C, Denmark
    Head Neck 25:711-6. 2003
    ....
  31. ncbi request reprint Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer
    Jørgen Johansen
    Danish Cancer Society, Department of Experimental Clinical Oncology, Aarhus
    Acta Oncol 41:369-80. 2002
    ....
  32. ncbi request reprint The Danish national guidelines for treatment of oral squamous cell carcinoma
    Anders Bilde
    Department of Otolaryngology, Head and Neck Surgery, Copenhagen University Hospital, Copenhagen, Denmark
    Acta Oncol 45:294-9. 2006
    ..In addition the establishment of a reference program facilitates national monitoring of the treatment using defined indicators and standards...
  33. doi request reprint Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol
    Mogens Blichert-Toft
    The Danish Breast Cancer Cooperative Group, DBCG, Rigshospitalet, Copenhagen, Denmark
    Acta Oncol 47:672-81. 2008
    ..Local failures as a first event consistent with new primaries are strongly associated with BCS, whereas true recurrence predominates after mastectomy...
  34. ncbi request reprint [Breast cancer]
    Mogens Blichert-Toft
    H S Rigshospitalet, endokrin and mammakirurgisk klinik CE, Finsencentret, Onkologisk afdeling
    Ugeskr Laeger 164:3023-6. 2002